What are stock appreciation rights (SARs) and performance share units (PSUs) and why are they being awarded?

Stock Appreciation Rights (SARs) and Performance Share Units (PSUs) are forms of equity-based compensation. SARs grant the holder the right to receive the increase in value of a company's stock over a certain period, often settled in cash or stock. PSUs are awarded with the expectation that specific performance metrics (like earnings per share) will be met over a set period, after which the units convert into company stock. HCA is awarding these to its top executives to incentivize them to drive company performance, enhance shareholder value, and align their financial interests with those of the shareholders, while also aiding in executive retention.

How are these awards structured in terms of vesting and payout?

The Stock Appreciation Rights (SARs) are time-based, meaning they vest gradually over four years, with 25% vesting on each anniversary of the grant date. The Performance Share Units (PSUs) are performance-based, tied to the company's cumulative earnings per share over a three-year period. The payout for PSUs can range from 0% if performance targets are not met, up to 200% of the target award if performance exceeds expectations. Both awards are ultimately settled in HCA's common stock.

What happens to these awards if there is a change in control of HCA?

The award agreements include provisions for change in control scenarios. If the acquiring company assumes the awards, they generally continue to vest based on the original schedule, with accelerated vesting for SARs and conversion to time-based vesting for PSUs under certain termination conditions. If the acquiring company does not assume the awards, both SARs and PSUs may vest immediately or be paid out in connection with the change in control event, based on specific terms outlined in the agreements.

Who are the key executives receiving these awards and what is the significance?

The awards are for named executive officers, including Chairman and CEO R. Milton Johnson, CFO William B. Rutherford, COO Samuel N. Hazen, and other key group presidents. The largest grants, both in SARs and target PSUs, were awarded to the CEO, reflecting his leadership role and accountability for overall company performance. This distribution underscores the company's strategy to incentivize its senior leadership team through significant equity stakes tied to the company's financial success.

HCA 8-K: Leadership Changes

Summary

This 8-K filing from HCA Holdings, Inc. on February 4, 2015, primarily reports on the Compensation Committee's approval of stock appreciation rights (SARs) and performance share units (PSUs) for key executive officers. These awards are designed to align executive compensation with the company's stock performance and long-term financial goals. The SARs are time-based and vest over four years, while PSUs are tied to a three-year cumulative earnings per share (EPS) performance period, with potential payouts ranging from 0% to 200% of the target award. For investors, this filing signals a focus on executive retention and motivation through equity-based compensation. The structure of the awards, particularly the performance-based nature of the PSUs, suggests management is incentivized to achieve sustained EPS growth. The inclusion of change-in-control provisions in both SAR and PSU agreements is a standard practice to ensure executive continuity and alignment during potential ownership transitions.

Key Highlights

1HCA Holdings, Inc. Compensation Committee approved awards of stock appreciation rights (SARs) and performance share units (PSUs) to named executive officers on January 29, 2015, with grants effective February 4, 2015.
2R. Milton Johnson, Chairman and CEO, received the largest grants: 156,000 SARs and a target of 62,400 PSUs.
3Stock Appreciation Rights (SARs) have a base price equal to the closing stock price on the grant date and vest over four years.
4SARs will be settled in shares of HCA's common stock and include provisions for accelerated vesting upon certain termination events or change in control.
5Performance Share Units (PSUs) are tied to cumulative earnings per share (EPS) over a three-year period, with payout potential ranging from 0% to 200% of the target award.
6PSU payouts will be made in shares of HCA's common stock, contingent upon meeting performance targets.
7Both SARs and PSUs are granted under the company's 2006 Stock Incentive Plan and include provisions for change in control scenarios.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Feb 4, 2015)

Summary

Key Highlights

Frequently Asked Questions